Completed

Immune Mechanisms During SAPHO Syndrome and Treatment by Etarnecept

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Bone Diseases+2

+ Bone Diseases, Developmental

+ Musculoskeletal Diseases

From 1 to 70 Years
+3 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: November 2005
See protocol details

Summary

Principal SponsorAssistance Publique - Hôpitaux de Paris
Last updated: September 19, 2012
Sourced from a government-validated database.Claim as a partner

Study start date: November 1, 2005

Actual date on which the first participant was enrolled.

The aetiology of SAPHO syndrome seems to involve genetic, infectious and immunological components. The investigators examined innate and adaptative immune responses in SAPHO syndrome as compared with psoriatic arthritis and rheumatoid arthritis.

NCT01688219
Principal SponsorAssistance Publique - Hôpitaux de Paris
Last updated: September 19, 2012
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

39 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 1 to 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Bone DiseasesBone Diseases, DevelopmentalMusculoskeletal DiseasesOsteochondrodysplasiasAcquired Hyperostosis Syndrome

Criteria

2 inclusion criteria required to participate
Clinical diagnosis of SAPHO syndrome
Must have bone lesions
1 exclusion criteria prevent from participating
Infliximab treatment

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has no location dataSave this study to your profile to know when the location data is available.
CompletedNo study centers